Home
Solution
Impact
Science
- Publications
About
- Team and Board
News and Events
Contact

Month: December 2025

First Scientific Publication Reporting Clinical Trial Results for Xinnate’s Proprietary Drug Candidate TCP-25

2025-12-22-First Scientific Publication Reporting Clinical Trial Results for Xinnate’s Proprietary Drug Candidate TCP-25

by Anna-Karin Lindqvist

Xinnate Completes Oversubscribed Share Issue of SEK 38,5m

Xinnate Completes Oversubscribed Share Issue of SEK 38,5m

by Anna-Karin Lindqvist

Xinnate Receives FDA IND Approval for TCP-25, Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis Bullosa

2025-12-10 Xinnate Receives FDA IND Approval for TCP-25 Enabling Pivotal Phase 2-3 STEP Study in EB

by Anna-Karin Lindqvist

Recent Posts

First Scientific Publication Reporting Clinical Trial Results for Xinnate’s Proprietary Drug Candidate TCP-25
Xinnate Completes Oversubscribed Share Issue of SEK 38,5m
Xinnate Receives FDA IND Approval for TCP-25, Enabling Pivotal Phase 2/3 STEP Study in Epidermolysis Bullosa
EB 2026: 20-22 Jan 2026
EB Awareness week: 25-31 Oct 2025

Archives

December 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
January 2025
December 2024
September 2024
May 2024
March 2024
February 2024
March 2023
October 2022
September 2022
July 2022
March 2022
August 2021
October 2020
January 2020

© 2026 Xinnate. All rights reserved